Movement Disorders (revue) - Curation (Ncbi)

Index « Keywords » - entrée « Antiparkinson Agents (therapeutic use) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Antiparkinson Agents (supply & distribution) < Antiparkinson Agents (therapeutic use) < Antiparkinson Agents (toxicity)  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 592.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000011 (1999) E. Moro [Italie] ; A. AlbaneseApomorphine and levodopa challenge in patients with a focal midbrain lesion.
000024 (1999) F. Stocchi [Italie] ; C. Farina ; G. Nordera ; S. RuggieriImplantable venous access system for apomorphine infusion in complicated Parkinson's disease.
000045 (1999) R B Innis [États-Unis] ; K L Marek ; K. Sheff ; S. Zoghbi ; J. Castronuovo ; A. Feigin ; J P SeibylEffect of treatment with L-dopa/carbidopa or L-selegiline on striatal dopamine transporter SPECT imaging with [123I]beta-CIT.
000063 (1999) L E Davis [États-Unis] ; J C AdairParkinsonism from methanol poisoning: benefit from treatment with anti-Parkinson drugs.
000064 (1999) M C Prevett [Royaume-Uni] ; M N RossorCentral pontine and extrapontine myelinolysis presenting with parkinsonism in a patient with cystic fibrosis.
000080 (1999) K A Reardon [Australie] ; M. Shiff ; P A KempsterEvolution of motor fluctuations in Parkinson's disease: a longitudinal study over 6 years.
000088 (1999) W. Ondo [États-Unis] ; C. Hunter ; M. Almaguer ; Joseph Jankovic [États-Unis]A novel sublingual apomorphine treatment for patients with fluctuating Parkinson's disease.
000112 (1999) Y. Furukawa ; S J KishDopa-responsive dystonia: recent advances and remaining issues to be addressed.
000113 (1999) W J Weiner [États-Unis]The initial treatment of Parkinson's disease should begin with levodopa.
000119 (1999) P. Barbanti [Italie] ; G. Fabbrini ; A. Ricci ; R. Cerbo ; E. Bronzetti ; B. Caronti ; C. Calderaro ; L. Felici ; F. Stocchi ; G. Meco ; F. Amenta ; G L LenziIncreased expression of dopamine receptors on lymphocytes in Parkinson's disease.
000139 (1999) D. Mathen [Royaume-Uni] ; C D Marsden ; K P BhatiaSSRI-induced reversal of levodopa benefit in two patients with dopa-responsive dystonia.
000183 (2000) L V Metman ; S. Konitsiotis ; T N ChasePathophysiology of motor response complications in Parkinson's disease: hypotheses on the why, where, and what.
000190 (2000) C. Ramaker [Pays-Bas] ; W J Van De Beek ; M J Finken ; B J Van HiltenThe efficacy and safety of adjunct bromocriptine therapy for levodopa-induced motor complications: a systematic review.
000216 (2000) J H Friedman [États-Unis] ; S A FactorAtypical antipsychotics in the treatment of drug-induced psychosis in Parkinson's disease.
000217 (2000) C W Olanow [États-Unis] ; A H Schapira ; T. RothWaking up to sleep episodes in Parkinson's disease.
000229 (2000) N A Leopold [États-Unis]Risperidone treatment of drug-related psychosis in patients with parkinsonism.
000238 (2000) A J Manson [Royaume-Uni] ; E. Iakovidou ; A J LeesIdazoxan is ineffective for levodopa-induced dyskinesias in Parkinson's disease.
000240 (2000) S. Frucht [États-Unis] ; S. Fahn ; S. Chin ; V. Dhawan ; D. EidelbergLevodopa-induced dyskinesias in autopsy-proven cortical-basal ganglionic degeneration.
000271 (2000) C G Goetz [États-Unis] ; G T Stebbins ; L M BlasucciDifferential progression of motor impairment in levodopa-treated Parkinson's disease.
000272 (2000) R A Hauser [États-Unis] ; W C Koller ; J P Hubble ; T. Malapira ; K. Busenbark ; C W OlanowTime course of loss of clinical benefit following withdrawal of levodopa/carbidopa and bromocriptine in early Parkinson' s disease.
000274 (2000) M D Welsh [États-Unis] ; E. Dorflinger ; D. Chernik ; C. WatersIllness impact and adjustment to Parkinson's disease: before and after treatment with tolcapone.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Antiparkinson Agents (therapeutic use)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Antiparkinson Agents (therapeutic use)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Antiparkinson Agents (therapeutic use)
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024